Omnicell (OMCL)
(Delayed Data from NSDQ)
$29.31 USD
+0.02 (0.07%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $29.55 +0.24 (0.82%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth F Momentum C VGM
Brokerage Reports
Omnicell, Inc. [OMCL]
Reports for Purchase
Showing records 81 - 100 ( 334 total )
Company: Omnicell, Inc.
Industry: Medical Info Systems
1Q Strong Beat + 2Q Guidance Suggesting Tracking Ahead of Expectations; Services Revenue Growing Faster Than Prior Expectations
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Healthcare IT: Proprietary Healthcare Credit Card Transaction Data
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Guidance Offers Clearing Event with 1H23 Trough; Remain OW as the Worst Seems to Be Behind Us
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
4Q Beat, but More Muted FY23 Outlook with Further Cost Cutting; CFO Transition Announced
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Read Throughs from PINC Guide Down: Weaker Hospital Volumes
Provider: KeyBanc Capital Markets
Analyst: Research Department